Fertility preservation in gynecologic cancer

Abstract

           The demand for fertility preservation for young patients has greatly increased, The ASCO recommends that education and informed consent about the possibility of infertility with patients and discuss fertility preservation options. However, the most important point is cancer treatment should take top priority, without being delayed or interfered by fertility preservation Because the higher incidence of gynecologic cancers were diagnosed before completion reproductive age. Standard gynecologic cancer treatment by radical surgery, chemotherapy or chemoradiation induce permanent damage of reproductive functions.
          Thus, we focused the fertility sparing surgery in early stage cervical cancer and the future of assisted reproductive techniques for more advanced stage. A conservative surgery in early ovarian cancer, BOT and ovarian germ cell tumors and conservative management with progesterone in early endometrial cancer. Benefits, risks and safety of fertility sparing management must be discussed with patients.